Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?. Issue 2 (21st October 2020) - Lwin, May; Holroyd, Christopher; Wallis, Dinny; Davidson, Brian; Goulston, Lyndsey; de Graaf, Hans; Edwards, Christopher J